Vivimed Labs Limited (NSE:VIVIMEDLAB)
India · Delayed Price · Currency is INR 5.50
+0.10 (1.85%)
Nov 11, 2026, 2:23 PM IST
Vivimed Labs Market Cap
Vivimed Labs has a market cap or net worth of 456.03 million as of November 10, 2026. It is the 45,010th most valuable company in the world and the 4,055th biggest in India. Its market cap has increased by 11.11% in one year.
Market Cap
456.03M
Enterprise Value
4.42B
Revenue
763.08M
Global Rank
Country Rank
#4,055 India
PE Ratio
n/a
ChartMarket Cap Chart
Since August 17, 2005, Vivimed Labs's market cap has decreased from 1.04B to 456.03M, a decrease of -56.15%. That is a compound annual growth rate of -3.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 456.03M | -68.87% |
| Dec 31, 2025 | 1.47B | 61.37% |
| Dec 30, 2022 | 907.91M | -49.54% |
| Dec 31, 2021 | 1.80B | 20.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.37B |
| Amanta Healthcare | 7.85B |
| Valiant Laboratories | 6.06B |
| Nectar Lifesciences | 1.99B |
| Brooks Laboratories | 1.94B |
| Par Drugs and Chemicals | 1.39B |
| Balaxi Pharmaceuticals | 1.25B |